FI20011517A - Förfarande för påvisning av alkoholkonsumtion som används vid förfarandet och deras framställning - Google Patents

Förfarande för påvisning av alkoholkonsumtion som används vid förfarandet och deras framställning Download PDF

Info

Publication number
FI20011517A
FI20011517A FI20011517A FI20011517A FI20011517A FI 20011517 A FI20011517 A FI 20011517A FI 20011517 A FI20011517 A FI 20011517A FI 20011517 A FI20011517 A FI 20011517A FI 20011517 A FI20011517 A FI 20011517A
Authority
FI
Finland
Prior art keywords
antibody
phosphatidylalcohol
present
alcohol consumption
manufacture
Prior art date
Application number
FI20011517A
Other languages
English (en)
Finnish (fi)
Other versions
FI20011517A0 (sv
FI112825B (sv
Inventor
Minna Hannuksela
Marja Liisanantti
Markku Savolainen
Original Assignee
Minna Hannuksela
Marja Liisanantti
Markku Savolainen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minna Hannuksela, Marja Liisanantti, Markku Savolainen filed Critical Minna Hannuksela
Publication of FI20011517A0 publication Critical patent/FI20011517A0/sv
Priority to FI20011517A priority Critical patent/FI112825B/sv
Priority to US10/483,663 priority patent/US20040203070A1/en
Priority to JP2003515859A priority patent/JP4192092B2/ja
Priority to ES02748901T priority patent/ES2312597T3/es
Priority to PCT/FI2002/000626 priority patent/WO2003010539A1/en
Priority to DE60228973T priority patent/DE60228973D1/de
Priority to AT02748901T priority patent/ATE408830T1/de
Priority to EP02748901A priority patent/EP1412747B1/en
Publication of FI20011517A publication Critical patent/FI20011517A/sv
Application granted granted Critical
Publication of FI112825B publication Critical patent/FI112825B/sv

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/98—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving alcohol, e.g. ethanol in breath
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Liquid Crystal (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI20011517A 2001-07-11 2001-07-11 Förfarande för påvisning av alkoholkonsumtion, medel som används vid förfarandet och deras framställning FI112825B (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FI20011517A FI112825B (sv) 2001-07-11 2001-07-11 Förfarande för påvisning av alkoholkonsumtion, medel som används vid förfarandet och deras framställning
PCT/FI2002/000626 WO2003010539A1 (en) 2001-07-11 2002-07-10 Method and means for detecting alcohol consumption
JP2003515859A JP4192092B2 (ja) 2001-07-11 2002-07-10 アルコール消費量を検出するための方法および手段
ES02748901T ES2312597T3 (es) 2001-07-11 2002-07-10 Procedimiento y anticuerpo para detectar el consumo de alcohol.
US10/483,663 US20040203070A1 (en) 2001-07-11 2002-07-10 Method and means for detecting alcohol consumption
DE60228973T DE60228973D1 (en) 2001-07-11 2002-07-10 Onsum
AT02748901T ATE408830T1 (de) 2001-07-11 2002-07-10 Verfahren und antikörper zum nachweis von alkoholkonsum
EP02748901A EP1412747B1 (en) 2001-07-11 2002-07-10 Method and antibody for detecting alcohol consumption

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20011517A FI112825B (sv) 2001-07-11 2001-07-11 Förfarande för påvisning av alkoholkonsumtion, medel som används vid förfarandet och deras framställning
FI20011517 2001-07-11

Publications (3)

Publication Number Publication Date
FI20011517A0 FI20011517A0 (sv) 2001-07-11
FI20011517A true FI20011517A (sv) 2003-01-12
FI112825B FI112825B (sv) 2004-01-15

Family

ID=8561635

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20011517A FI112825B (sv) 2001-07-11 2001-07-11 Förfarande för påvisning av alkoholkonsumtion, medel som används vid förfarandet och deras framställning

Country Status (8)

Country Link
US (1) US20040203070A1 (sv)
EP (1) EP1412747B1 (sv)
JP (1) JP4192092B2 (sv)
AT (1) ATE408830T1 (sv)
DE (1) DE60228973D1 (sv)
ES (1) ES2312597T3 (sv)
FI (1) FI112825B (sv)
WO (1) WO2003010539A1 (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2739076A1 (en) * 2008-10-02 2010-04-08 Celtaxsys, Inc. Methods of modulating the negative chemotaxis of immune cells
US9239280B2 (en) * 2012-06-16 2016-01-19 Atherotech, Inc. Measurement of serum lipoproteins
WO2013188879A1 (en) 2012-06-16 2013-12-19 Atherotech, Inc. Measurement of serum lipoproteins

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4459362A (en) * 1982-02-02 1984-07-10 Hana Biologics, Inc. Immunoassay of phospholipid, such as phosphatidyl choline, in fluids such as amniotic
US4388412A (en) * 1982-02-02 1983-06-14 Hana Biologics, Inc. Immunoassay of phospholipid, such as phosphatidylcholine, in fluids such as amniotic
US5066583A (en) * 1988-12-21 1991-11-19 Wisconsin Alumni Research Foundation Method for distinguishing alcoholics from non-alcoholics
GB9207731D0 (en) * 1992-04-07 1992-05-27 Proteus Molecular Design Improvements in or relating to vaccines
US5698721A (en) * 1992-12-17 1997-12-16 Megabios Corporation Catonic amphiphiles
US5856196A (en) * 1993-10-25 1999-01-05 Beth Israel Hospital Processes for quantitating phosphoglycerides in a lipid mixture and diagnostic uses therefor

Also Published As

Publication number Publication date
US20040203070A1 (en) 2004-10-14
FI20011517A0 (sv) 2001-07-11
EP1412747B1 (en) 2008-09-17
WO2003010539A1 (en) 2003-02-06
JP4192092B2 (ja) 2008-12-03
EP1412747A1 (en) 2004-04-28
ATE408830T1 (de) 2008-10-15
FI112825B (sv) 2004-01-15
JP2004536322A (ja) 2004-12-02
ES2312597T3 (es) 2009-03-01
DE60228973D1 (en) 2008-10-30

Similar Documents

Publication Publication Date Title
RU2005131842A (ru) Моноклональное антитело и продуцирующая его гибридома
DE69735294D1 (de) Spezifische monoklonale antikörperfür die extrazelluläre domäne von protasta-spezifischem membranantigen
EP1381864A4 (en) DETECTION OF CANDIDA
WO2003048302A3 (en) Identifying anti-tumor targets or agents by lipid raft immunization and proteomics
WO2002041842A3 (en) Antibody pti-hs7 for treatment of alzheimer's disease and other amyloidoses and parkinson's disease
NO992472D0 (no) FremgangsmÕte for Õ diagnostisere metabolske bensykdommer
SE0000675D0 (sv) Monoclonal antibodies
FI20011517A (sv) Förfarande för påvisning av alkoholkonsumtion som används vid förfarandet och deras framställning
EA200200435A1 (ru) Анализ лептина
CA2089395A1 (en) Monoclonal antibodies for detecting water treatment polymers
AU2002233800A1 (en) Method and kit for predicting cancer
ATE219247T1 (de) Methoden zur feststellung von alzheimerscher krankheit
DK1276752T3 (da) Fremgangsmåde til vurdering af risikoen for, at en person udvikler vaskulære komplikationer
ATE433575T1 (de) Neurotransmission-störungen
SE0002835D0 (sv) Method and kit for production of monoclonal antibodies
FR2828934B1 (fr) Test de l'immunite cellulaire par des peptides fixes sur support solide
ATE180282T1 (de) Antikörpertest zur erkennung von alkoholikern und zur überwachung der alkoholaufnahme
DE60336214D1 (de) Methoden zur analyse von antikörperdisulfidisomere
ATE239230T1 (de) Verbessertes verfahren zur bestimmung von allergien
EP0364971A3 (en) Process for the detection of legionella antigens in body fluids and the like, as well as a test kit for performing the process
IL160387A0 (en) Antigen mimotopes and vaccine against cancers
EP1202064A3 (en) Method for detecting antibodies to and antigens of fungal and yeast exposures
Maji et al. Cross-antigenicity between ruminal and hepatic paramphistomes and liver flukes of buffalo origin
NO20022276D0 (no) Human neurokinin-B-forlöper fra placenta
ATE343596T1 (de) Humane monoklonale antikörper gegen inselzellantigen ia-2

Legal Events

Date Code Title Description
MM Patent lapsed